1. Home
  2. CYTH vs EVTV Comparison

CYTH vs EVTV Comparison

Compare CYTH & EVTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • EVTV
  • Stock Information
  • Founded
  • CYTH 1990
  • EVTV 2012
  • Country
  • CYTH United States
  • EVTV United States
  • Employees
  • CYTH N/A
  • EVTV 14
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • EVTV Auto Manufacturing
  • Sector
  • CYTH Health Care
  • EVTV Consumer Discretionary
  • Exchange
  • CYTH Nasdaq
  • EVTV Nasdaq
  • Market Cap
  • CYTH 26.2M
  • EVTV 6.9M
  • IPO Year
  • CYTH N/A
  • EVTV 2017
  • Fundamental
  • Price
  • CYTH $0.76
  • EVTV $0.38
  • Analyst Decision
  • CYTH Buy
  • EVTV
  • Analyst Count
  • CYTH 3
  • EVTV 0
  • Target Price
  • CYTH $0.95
  • EVTV N/A
  • AVG Volume (30 Days)
  • CYTH 44.3K
  • EVTV 3.2M
  • Earning Date
  • CYTH 03-17-2025
  • EVTV 03-27-2025
  • Dividend Yield
  • CYTH N/A
  • EVTV N/A
  • EPS Growth
  • CYTH N/A
  • EVTV N/A
  • EPS
  • CYTH N/A
  • EVTV N/A
  • Revenue
  • CYTH $870,725.00
  • EVTV $1,730,010.00
  • Revenue This Year
  • CYTH N/A
  • EVTV N/A
  • Revenue Next Year
  • CYTH $24.49
  • EVTV N/A
  • P/E Ratio
  • CYTH N/A
  • EVTV N/A
  • Revenue Growth
  • CYTH N/A
  • EVTV N/A
  • 52 Week Low
  • CYTH $0.55
  • EVTV $0.29
  • 52 Week High
  • CYTH $1.92
  • EVTV $3.20
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 54.14
  • EVTV 22.02
  • Support Level
  • CYTH $0.70
  • EVTV $0.29
  • Resistance Level
  • CYTH $0.87
  • EVTV $0.81
  • Average True Range (ATR)
  • CYTH 0.07
  • EVTV 0.13
  • MACD
  • CYTH -0.00
  • EVTV -0.04
  • Stochastic Oscillator
  • CYTH 49.91
  • EVTV 10.92

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

Share on Social Networks: